sabine ottilie

sabine ottilie

University of California, San Diego

H-index: 28

North America-United States

About sabine ottilie

sabine ottilie, With an exceptional h-index of 28 and a recent h-index of 18 (since 2020), a distinguished researcher at University of California, San Diego, specializes in the field of Antiviral drug discovery.

His recent articles reflect a diverse array of research interests and contributions to the field:

Cytoplasmic isoleucyl tRNA synthetase as an attractive multistage antimalarial drug target

Diverse evolutionary pathways challenge the use of collateral sensitivity as a strategy to suppress resistance

Advances in malaria pharmacology and the online guide to MALARIA PHARMACOLOGY: IUPHAR review 38

Human nuclear hormone receptor activity contributes to malaria parasite liver stage development

Development of Potent and Highly Selective Epoxyketone‐Based Plasmodium Proteasome Inhibitors

The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple Plasmodium kinases and life cycle stages

Development of Highly Selective Epoxyketone-based Plasmodium Proteasome Inhibitors with Negligible Cytotoxicity

Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy

sabine ottilie Information

University

Position

___

Citations(all)

3347

Citations(since 2020)

1183

Cited By

2428

hIndex(all)

28

hIndex(since 2020)

18

i10Index(all)

40

i10Index(since 2020)

29

Email

University Profile Page

Google Scholar

sabine ottilie Skills & Research Interests

Antiviral drug discovery

Top articles of sabine ottilie

Cytoplasmic isoleucyl tRNA synthetase as an attractive multistage antimalarial drug target

Science translational medicine

2023/3/8

Diverse evolutionary pathways challenge the use of collateral sensitivity as a strategy to suppress resistance

Elife

2023/9/22

Sabine Ottilie
Sabine Ottilie

H-Index: 13

Advances in malaria pharmacology and the online guide to MALARIA PHARMACOLOGY: IUPHAR review 38

2023/8

Human nuclear hormone receptor activity contributes to malaria parasite liver stage development

Cell chemical biology

2023/5/18

Development of Potent and Highly Selective Epoxyketone‐Based Plasmodium Proteasome Inhibitors

Chemistry–A European Journal

2023/4/6

The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple Plasmodium kinases and life cycle stages

Science translational medicine

2022/10/19

Development of Highly Selective Epoxyketone-based Plasmodium Proteasome Inhibitors with Negligible Cytotoxicity

bioRxiv

2022/8/7

Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy

Science

2022/6/3

The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistance

Cell chemical biology

2022/5/19

Semi-Synthetic Analogues of Cryptolepine as a Potential Source of Sustainable Drugs for the Treatment of Malaria, Human African Trypanosomiasis, and Cancer. Front. Pharmacol …

Frontiers in Pharmacology

2022/4/26

Collateral sensitivity as a strategy to suppress resistance emergence: the challenge of diverse evolutionary pathways

bioRxiv

2022/4/7

Sabine Ottilie
Sabine Ottilie

H-Index: 13

Chemogenomics identifies acetyl-coenzyme A synthetase as a target for malaria treatment and prevention

Cell chemical biology

2022/2/17

Adaptive laboratory evolution in S. cerevisiae highlights role of transcription factors in fungal xenobiotic resistance

Communications Biology

2022/2/11

MalDA, accelerating malaria drug discovery

2021/6/1

PfMFR3: A Multidrug-Resistant Modulator in Plasmodium falciparum

ACS Infectious Diseases

2021/3/15

Defining the Yeast Resistome through in vitro Evolution and Whole Genome Sequencing

bioRxiv

2021/2/17

Identification and profiling of a novel diazaspiro [3.4] octane chemical series active against multiple stages of the human malaria parasite plasmodium falciparum and …

Journal of medicinal chemistry

2021/2/12

Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box

Nature communications

2021/1/11

Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome

Proceedings of the National Academy of Sciences

2021/9/28

Prioritization of molecular targets for antimalarial drug discovery

ACS infectious diseases

2021/9/15

See List of Professors in sabine ottilie University(University of California, San Diego)

Co-Authors

academic-engine